nach oben

Erschienen in:

01.12.2017 | Original Article

Malnutrition and sarcopenia in a large cohort of patients with systemic sclerosis

verfasst von: C. Caimmi, P. Caramaschi, A. Venturini, E. Bertoldo, E. Vantaggiato, O. Viapiana, M. Ferrari, G. Lippi, L. Frulloni, M. Rossini

Erschienen in: Clinical Rheumatology | Ausgabe 4/2018

Einloggen, um Zugang zu erhalten

Abstract

Systemic sclerosis (SSc) is an autoimmune disease which may lead to malnutrition. Previous studies have defined it with different criteria. No thorough evaluations of sarcopenia in SSc are available. The aim of the present study was to assess the prevalence and the potential association of malnutrition and sarcopenia in a large cohort of SSc cases. A total of 141 SSc consecutive outpatients were enrolled. Body composition was analyzed by densitometry. Malnutrition was defined according to recently published ESPEN criteria, whereas sarcopenia was diagnosed in patients with reduced skeletal muscle index. Malnutrition was diagnosed in 9.2% of patients (95% CI, 4.4–14.0%). Malnourished patients had worse gastrointestinal symptoms according to UCLA SCTC GIT 2.0 questionnaire (p = 0.007), lower physical activity (p = 0.028), longer disease duration (p = 0.019), worse predicted DLCO/VA and FVC (p = 0.009, respectively), worse disease severity according to Medsger severity score (p < 0.001), lower hemoglobin (p = 0.023), and fat-free mass (p < 0.001) and were more often sarcopenic (p < 0.001). In multivariate analysis, only FVC (p = 0.006) and disease severity (p = 0.003), in particular for the lungs (p = 0.013), were confirmed to be worse in malnourished patients. Sarcopenia was diagnosed in 29\140 patients (20.7%; 95% CI, 14.0–27.4%); 11\29 were also malnourished. In multivariate analysis, sarcopenic patients had longer disease duration (p = 0.049), worse DLCO/VA (p = 0.002), and lung (p = 0.006) and skin (p = 0.014) involvement. In SSc, malnutrition defined with ESPEN criteria was found to be lower than previously reported. Sarcopenia was found to be somewhat common. Lung involvement was significantly associated with nutritional status and may not be explained only by muscle weakness.

Butt S, Emmanuel A (2013) Systemic sclerosis and gut. Expert Rev Gastroenterol Hepatol 7(4):331–339. https://doi.org/10.1586/egh.13.22 CrossRefPubMed

Akesson A, Gustafson T, Wollheim F, Brismar J (1987) Esophageal dysfunction and radionuclide transit in progressive systemic sclerosis. Scand J Rheumatol 16(4):291–299. https://doi.org/10.3109/03009748709102931 CrossRefPubMed

Sallam H, McNearney TA, Chen JD (2006) Systematic review: phatophysiology and management of gastrointestinal dysmotility in systemic sclerosis (scleroderma). Aliment Pharmacol Ther 23(6):691–712. https://doi.org/10.1111/j.1365-2036.2006.02804.x CrossRefPubMed

Sobotka L (2012) Basics in clinical nutrition, 4th edn. Galen, Prague

Baron M, Hudson M, Steele R, Canadian scleroderma research group (2009) Malnutrition is common in systemic sclerosis: results from the Canadian scleroderma research group database. J Rheumatol 36(12):2737–2743. https://doi.org/10.3899/jrheum.090694 CrossRefPubMed

Krause L, Becker MO, Brueckner CS, Bellinghausen CJ, Becker C, Schneider U, Haeupl T, Hanke K, Hensel-Wiegel K, Ebert H, Ziemer S, Ladner UM, Pirlich M, Burmester GR, Riemekasten G (2010) Nutritional status as marker for disease activity and severity predicting mortality in patients with systemic sclerosis. Ann Rheum Dis 69(11):1951–1957. https://doi.org/10.1136/ard.2009.123273 CrossRefPubMed

Murtaugh M, Frech T (2013) Nutritional status and gastrointestinal symptoms in systemic sclerosis patients. Clin Nutr 32(1):130–135. https://doi.org/10.1016/j.clnu.2012.06.005 CrossRefPubMed

Caporali R, Caccialanza R, Bonino C, Klersy C, Cereda E, Xoxi B, Crippa A, Rava ML, Orlandi M, Bonardi C, Cameletti B, Codullo V, Montecucco C (2012) Disease-related malnutrition in outpatients with systemic sclerosis. Clin Nutr 31(5):666–671. https://doi.org/10.1016/j.clnu.2012.02.010 CrossRefPubMed

Rosato E, Gigante A, Gasperini ML, Molinaro I, Di Lazzaro Giraldi G, Afeltra A, Amoroso D, Salsano F, Rossi Fanelli F, Laviano A (2014) Nutritional status measured by BMI is impaired and correlates with left ventricular mass in patients with systemic sclerosis. Nutrition 30(2):204–209. https://doi.org/10.1016/j.nut.2013.07.025 CrossRefPubMed

10.

Cereda E, Codullo V, Klersy C, Breda S, Crippa A, Rava ML, Orlandi M, Bonardi C, Fiorentini ML, Caporali R, Caccialanza R (2014) Disease-related nutritional risk and mortality in systemic sclerosis. Clin Nutr 33(3):558–561. https://doi.org/10.1016/j.clnu.2013.08.010 CrossRefPubMed

11.

Spanjer MJ, Bultink IEM, de van der Schueren MAE, Voskuyl AE (2017) Prevalence of malnutrition and validation of bioelectrical impedance analysis for the assessment of body composition in patients with systemic sclerosis. Rheumatology 56(6):1008–1012. https://doi.org/10.1093/rheumatology/kex014 CrossRefPubMed

12.

Gyger G, Baron M (2012) Gastrointestinal manifestations of scleroderma: recent progress in evaluation, pathogenesis, and management. Curr Rheumatol Rep 14(1):22–29. https://doi.org/10.1007/s11926-011-0217-3 CrossRefPubMed

13.

Isola G, Williams RC, Lo Gullo A, Ramaglia L, Matarese M, Iorio-Siciliano V, Cosio C, Matarese G (2017) Risk association between scleroderma disease characteristics, periodontitis, and tooth loss. Clin Rheumatol 36(12):2733–2741. https://doi.org/10.1007/s10067-017-3861-9 CrossRefPubMed

14.

Fielding RA, Vellas B, Evans WJ, Bhasin S, Morley JE, Newman AB, Abellan van Kan G, Andrieu S, Bauer J, Breuille D, Cederholm T, Chandler J, de Meynard C, Donini L, Harris T, Kannt A, Keime Guibert F, Onder G, Papanicolaou D, Rolland Y, Rooks D, Sieber C, Souhami E, Verlaan S, Zamboni M (2011) Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc 12(4):249–256. https://doi.org/10.1016/j.jamda.2011.01.003 CrossRefPubMed

15.

Ali S, Garcia JM (2014) Sarcopenia, cachexia and aging: diagnosis, mechanisms and therapeutic options—a mini-review. Gerontology 60(4):294–305. https://doi.org/10.1159/000356760 CrossRefPubMedPubMedCentral

16.

Marighela TF, Genaro Pde S, Pinheiro MM, Szejnfeld VL, Kayser C (2013) Risk factors for body composition abnormalities in systemic sclerosis. Clin Rheumatol 32(7):1037–1044. https://doi.org/10.1007/s10067-013-2235-1 CrossRefPubMed

17.

Cederholm T, Bosaeus I, Barazzoni R, Bauer J, Van Gossum A, Klek S, Muscaritoli M, Nyulasi I, Ockenga J, Schneider SM, de van der Schueren MAE, Singer P (2015) Diagnostic criteria for malnutrition: an ESPEN consensus statement. Clin Nutr 34(3):335–340. https://doi.org/10.1016/j.clnu.2015.03.001 CrossRefPubMed

18.

Medsger TA, Bombardieri S, Czirjak L, Scorza R, Della Rossa A, Bencivelli W (2003) Assessment of disease severity and prognosis. Clin Exp Rheumatol 21(3 suppl 29):S42–S46PubMed

19.

Khanna D, Hays RD, Maranian P, Seibold JR, Impens A, Mayes MD, Clements PJ, Getzug T, Fathi N, Bechtel A, de Furst (2009) Reliability and validity of UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract (UCLA SCTC GIT 2.0) instrument. Arthritis Rheum 61(9):1257–1263. https://doi.org/10.1002/art.24730 CrossRefPubMedPubMedCentral

20.

van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, Matucci-Cerinic M, Naden RP, Medsger TA Jr, Carreira PE, Riemekasten G, Clements PJ, Denton CP, Distler O, Allanore Y, de Furst, Gabrielli A, Mayes MD, van Laar JM, Seibold JR, Czirjak L, Steen VD, Inanc M, Kowal-Bielecka O, Müller-Ladner U, Valentini G, Veale DJ, Vonk MC, Walker UA, Chung L, Collier DH, Ellen Csuka M, Fessler BJ, Guiducci S, Herrick A, Hsu VM, Jimenez S, Kahaleh B, Merkel PA, Sierakowski S, Silver RM, Simms RW, Varga J, Pope JE (2013) 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative. Ann Rheum Dis 72(11):1747–1755. https://doi.org/10.1136/annrheumdis-2013-204424 CrossRefPubMed

21.

LeRoy EC, Black CM, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr et al (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15(2):202–205PubMed

22.

Akesson A, Fiori G, Krieg T, van den Hoogen FHJ, Seibold JR (2002) Assessment of skin, joint, tendon and muscle involvement. Clin Exp Rheumatol 21(3 suppl 29):S5–S8

23.

Valentini G, Della Rossa A, Bombardieri S, Bencivelli W, Silman AJ, D'Angelo S, Cerinic MM, Belch JF, Black CM, Bruhlmann P, Czirják L, de Luca A, Drosos AA, Ferri C, Gabrielli A, Giacomelli R, Hayem G, Inanc M, McHugh NJ, Nielsen H, Rosada M, Scorza R, Stork J, Sysa A, van den Hoogen FH, Vlachoyiannopoulos PJ (2001) European multicentre study to define disease activity criteria for systemic sclerosis. II. Identification of disease activity variables and development of preliminary activity indexes. Ann Rheum Dis 60(6):592–598. https://doi.org/10.1136/ard.60.6.592 CrossRefPubMedPubMedCentral

24.

Elia M (2003) Screening for malnutrition: a multidisciplinary responsibility. Development and use of the ‘malnutrition universal screening tool’ (‘MUST’) for adults. Malnutrition Advisory Group (MAG), a standing committee of BAPEN Redditch, Worcs

25.

Stratton RJ, Hackston A, Longmore D, Dixon R, Price S, Stroud M, King C, Elia M (2004) Malnutrition in hospital outpatients and inpatients: prevalence, concurrent validity and ease of use of the ‘malnutrition universal screening tool’ (‘MUST’) for adults. Br J Nutr 92(05):799–808. https://doi.org/10.1079/BJN20041258 CrossRefPubMed

26.

Neelemaat F, Meijers J, Kruizenga H, van Ballegooijen H, van Bokhorst-de van der Schueren M (2011) Comparison of five malnutrition screening tools in one hospital inpatient sample. J Clin Nurs 20(15-16):2144–2152. https://doi.org/10.1111/j.1365-2702.2010.03667.x CrossRefPubMed

27.

Leistra E, Langius JA, Evers AM, van Bokhorst-de van der Schueren MA, Visser M, de Vet HC et al (2013) Validity of nutritional screening with MUST and SNAQ in hospital outpatients. Eur J Clin Nutr 67(7):738–742. https://doi.org/10.1038/ejcn.2013.85 CrossRefPubMed

28.

Baumgartner R, Koehler K, Gallagher D, Romero L, Heymsfield SB, Ross RR et al (1998) Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol 147(8):755–763. https://doi.org/10.1093/oxfordjournals.aje.a009520 CrossRefPubMed

29.

Craig CL, Marshall AL, Sjostrom M, Bauman AE, Booth ML, Ainsworth BE et al (2003) International Physical Activity Questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 35(8):1381–1395. https://doi.org/10.1249/01.MSS.0000078924.61453.FB CrossRefPubMed

30.

March C, Siegert E, Preis E, Makowka A, Buttgereit F, Riemekasten G et al (2017) Prevalence of sarcopenia in patients with systemic sclerosis according to the revised criteria of the european working group on sarcopenia in older people. Ann Rheum Dis 15:897–898

31.

Schweitzer L, Geisler C, Johannsen M, Glüer CC, Müller MJ (2017) Associations between body composition, physical capabilities and pulmonary function in healthy older adults. Eur J Clin Nutr 71(3):389–394. https://doi.org/10.1038/ejcn.2016.146 CrossRefPubMed

32.

Massaro D, Massaro GD (2004) Hunger disease and pulmonary alveoli. Am J Respir Crit Care Med 170(7):723–724. https://doi.org/10.1164/rccm.2408002 CrossRefPubMed

33.

Tyndall AJ, Bannert B, Vonk M, Airò P, Cozzi F, Carreira PE et al (2010) Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database. Ann Rheum Dis 69(10):1809–1815. https://doi.org/10.1136/ard.2009.114264 CrossRefPubMed

34.

Caimmi C, Caramaschi P, Barausse G, Orsolini G, Idolazzi L, Gatti D, Viapiana O, Adami S, Biasi D, Rossini M (2016) Bone metabolism in a large cohort of patients with systemic sclerosis. Calcif Tissue Int 99(1):23–29. https://doi.org/10.1007/s00223-016-0119-5 CrossRefPubMed

35.

Caramaschi P, Dalla Gassa A, Ruzzenente O, Volpe A, Ravagnani V, Tinazzi I, Barausse G, Bambara LM, Biasi D (2010) Very low levels of vitamin D in systemic sclerosis patients. Clin Rheumatol 29(12):1419–1425. https://doi.org/10.1007/s10067-010-1478-3 CrossRefPubMed

36.

Giuggioli D, Colaci M, Cassone G, Fallahi P, Lumetti F, Spinella A, Campomori F, Manfredi A, Manzini CU, Antonelli A, Ferri C (2017) Serum 25-OH vitamin D levels in systemic sclerosis: analysis of 140 patients and review of the literature. Clin Rheumatol 36(3):583–590. https://doi.org/10.1007/s10067-016-3535-z CrossRefPubMed

Titel: Malnutrition and sarcopenia in a large cohort of patients with systemic sclerosis
verfasst von: C. Caimmi
P. Caramaschi
A. Venturini
E. Bertoldo
E. Vantaggiato
O. Viapiana
M. Ferrari
G. Lippi
L. Frulloni
M. Rossini
Publikationsdatum: 01.12.2017
Verlag: Springer London
Erschienen in: Clinical Rheumatology / Ausgabe 4/2018
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI: https://doi.org/10.1007/s10067-017-3932-y

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2018

Inflammatory tenosynovitis and enthesitis induced by immune checkpoint inhibitor treatment

ADAM-17 is expressed in the inflammatory myopathy and is involved with interstitial lung disease

Long-term outcomes of daily oral vs. pulsed intravenous cyclophosphamide in a non-trial setting in ANCA-associated vasculitis

Correction to: Tubulointerstitial nephritis-induced hypophosphatemic osteomalacia in Sjögren’s syndrome: a case report and review of the literature

Can we have an overall osteoarthritis severity score for the patellofemoral joint using magnetic resonance imaging? Reliability and validity